JP5919597B2 - デオキシコール酸およびその塩類の製剤 - Google Patents

デオキシコール酸およびその塩類の製剤 Download PDF

Info

Publication number
JP5919597B2
JP5919597B2 JP2014527128A JP2014527128A JP5919597B2 JP 5919597 B2 JP5919597 B2 JP 5919597B2 JP 2014527128 A JP2014527128 A JP 2014527128A JP 2014527128 A JP2014527128 A JP 2014527128A JP 5919597 B2 JP5919597 B2 JP 5919597B2
Authority
JP
Japan
Prior art keywords
composition
salt
sodium
deoxycholic acid
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2014527128A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014524467A (ja
Inventor
エミル ホッジ,ロバート
エミル ホッジ,ロバート
ダグラス ウェブスター,ジェフリー
ダグラス ウェブスター,ジェフリー
エム. モリアーティ,ロバート
エム. モリアーティ,ロバート
Original Assignee
キテラ バイオファーマシューティカルズ,インコーポレイテッド
キテラ バイオファーマシューティカルズ,インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45569726&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP5919597(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by キテラ バイオファーマシューティカルズ,インコーポレイテッド, キテラ バイオファーマシューティカルズ,インコーポレイテッド filed Critical キテラ バイオファーマシューティカルズ,インコーポレイテッド
Publication of JP2014524467A publication Critical patent/JP2014524467A/ja
Application granted granted Critical
Publication of JP5919597B2 publication Critical patent/JP5919597B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
JP2014527128A 2011-08-23 2011-08-23 デオキシコール酸およびその塩類の製剤 Active JP5919597B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/048806 WO2013028177A1 (fr) 2011-08-23 2011-08-23 Préparations d'acide désoxycholique et sels associés

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016055666A Division JP6219430B2 (ja) 2016-03-18 2016-03-18 デオキシコール酸およびその塩類の製剤

Publications (2)

Publication Number Publication Date
JP2014524467A JP2014524467A (ja) 2014-09-22
JP5919597B2 true JP5919597B2 (ja) 2016-05-18

Family

ID=45569726

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014527128A Active JP5919597B2 (ja) 2011-08-23 2011-08-23 デオキシコール酸およびその塩類の製剤

Country Status (18)

Country Link
JP (1) JP5919597B2 (fr)
KR (5) KR101919269B1 (fr)
CN (3) CN108619089A (fr)
AU (3) AU2011375432B2 (fr)
BR (1) BR112014000547B1 (fr)
CA (1) CA2842177C (fr)
CR (1) CR20140053A (fr)
EA (1) EA029305B1 (fr)
IL (1) IL230547A (fr)
IN (1) IN2014CN02188A (fr)
MX (1) MX350390B (fr)
MY (1) MY184277A (fr)
NZ (1) NZ620040A (fr)
PH (1) PH12016501175A1 (fr)
SG (1) SG2014013205A (fr)
UA (1) UA113522C2 (fr)
WO (1) WO2013028177A1 (fr)
ZA (1) ZA201401027B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
JP2018532806A (ja) * 2015-11-04 2018-11-08 キセラ バイオファーマシューティカルズ インコーポレイテッド デオキシコール酸およびその塩による蓄積脂肪の処置方法
KR101841193B1 (ko) * 2016-09-22 2018-03-22 이경락 저장성 지방 분해 조성물 및 그의 제조 방법
US20180078621A1 (en) * 2016-09-22 2018-03-22 Kyoung Lack Lee Composition for hypotonic lipolysis and manufacturing method thereof
WO2019203511A1 (fr) * 2018-04-16 2019-10-24 주식회사 펜믹스 Composition pharmaceutique d'acide désoxycholique
KR102172439B1 (ko) * 2018-12-05 2020-10-30 송미희 지방 분해용 조성물 및 이를 포함하는 주사제 조성물
KR102064864B1 (ko) 2019-02-08 2020-01-10 (주)제테마 국소 주사용 조성물
KR102111346B1 (ko) * 2019-08-20 2020-05-22 아영창 침전으로부터 안정한 소듐디옥시콜레이트를 포함하는 수용액상 조성물
KR20220026068A (ko) 2020-08-25 2022-03-04 강명범 지방 분해용 주사제 조성물
CN116617160A (zh) * 2023-07-25 2023-08-22 山东则正医药技术有限公司 水性混悬液及制备方法、冻干粉及应用、脂肪消减注射剂

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754709B1 (fr) 1996-10-23 1999-03-05 Sanofi Sa Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition
AU758679B2 (en) * 1998-07-24 2003-03-27 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
US6417179B1 (en) * 1998-10-13 2002-07-09 Craig G. Burkhart Ear wax solution
US20050048126A1 (en) * 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
DE10361067A1 (de) * 2003-12-22 2005-07-14 Aventis Pharma Deutschland Gmbh Medikamentöse Lipolyse von Fettansammlungen
MXPA06013437A (es) 2004-05-19 2007-03-23 Los Angeles Biomed Res Inst Uso de un detergente para la eliminacion no quirurgica de grasa.
US7754230B2 (en) 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
AU2006255097B2 (en) 2005-06-06 2012-02-09 Georgetown University Compositions and methods for lipo modeling
TW201011755A (en) 2008-09-10 2010-03-16 Skymedi Corp Flash memory system and its data recovery method
JP5420946B2 (ja) * 2009-03-23 2014-02-19 富士フイルム株式会社 胆汁酸を含むミノキシジル水性組成物
EP2645099A1 (fr) 2012-03-30 2013-10-02 Phares Pharmaceutical Research N.V. Compositions biopertinentes

Also Published As

Publication number Publication date
EA201490175A1 (ru) 2014-06-30
KR101919269B1 (ko) 2018-11-15
EA029305B1 (ru) 2018-03-30
AU2016202661B2 (en) 2018-02-22
PH12016501175B1 (en) 2017-12-11
CN103826608A (zh) 2014-05-28
JP2014524467A (ja) 2014-09-22
CN108619089A (zh) 2018-10-09
KR20170075016A (ko) 2017-06-30
AU2011375432A1 (en) 2014-02-06
UA113522C2 (xx) 2017-02-10
IN2014CN02188A (fr) 2015-05-29
CN108743522A (zh) 2018-11-06
BR112014000547A2 (pt) 2017-02-14
CA2842177C (fr) 2016-07-19
KR102034606B1 (ko) 2019-10-22
KR102073536B1 (ko) 2020-02-04
NZ620040A (en) 2016-06-24
KR20150000448A (ko) 2015-01-02
MY184277A (en) 2021-03-30
BR112014000547B1 (pt) 2021-11-09
AU2016202661A1 (en) 2016-05-19
KR20200013103A (ko) 2020-02-05
CA2842177A1 (fr) 2013-02-28
CR20140053A (es) 2014-06-12
MX2014001495A (es) 2014-04-25
MX350390B (es) 2017-09-06
IL230547A (en) 2017-02-28
KR20190119677A (ko) 2019-10-22
KR101751585B1 (ko) 2017-06-27
IL230547A0 (en) 2014-03-31
WO2013028177A1 (fr) 2013-02-28
AU2011375432B2 (en) 2016-02-04
AU2018202807B2 (en) 2020-01-16
PH12016501175A1 (en) 2017-12-11
SG2014013205A (en) 2014-05-29
AU2018202807A1 (en) 2018-05-10
KR20180123734A (ko) 2018-11-19
ZA201401027B (en) 2017-09-27

Similar Documents

Publication Publication Date Title
US20210252021A1 (en) Formulations of deoxycholic acid and salts thereof
JP5919597B2 (ja) デオキシコール酸およびその塩類の製剤
US20220072011A1 (en) Treatments of accumulated fat with deoxycholic acid and salts thereof
EP3305298B1 (fr) Formulations d'acide désoxycholique et sels associés
JP6219430B2 (ja) デオキシコール酸およびその塩類の製剤
JP6594486B2 (ja) デオキシコール酸およびその塩類の製剤
JP6356329B2 (ja) デオキシコール酸およびその塩類の製剤
EA034320B1 (ru) Композиции дезоксихолата натрия

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140801

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20150619

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150623

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150918

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151019

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160223

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160318

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160325

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160401

R150 Certificate of patent or registration of utility model

Ref document number: 5919597

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250